11 In fact they have now recognized the importance of the “quality of the intestinal selleck inhibitor bacteria”, and the impact that this has on the fermentation of malabsorbed carbohydrates.12 In their recent paper they have assembled measurements for various classes of immunoglobulins, and other markers of immune activation, that support a high level of exposure to gastrointestinal infections in childhood.11 Their new hypothesis is that it is this early priming that gives the African a more robust gut microflora, better able to withstand the insults in adult life. The corollary is also that if we expect fiber and oligosaccharides that are promoted as prebiotics

to enhance the proliferation of ‘good bacteria’, we have to start feeding these substrates to

our gut in the early years of life. In the meantime, it appears that eating a ‘healthy Western breakfast’ of milk with high-fiber cereals, whole grain bread with honey, washed down with apple juice, is perhaps the worst way to start off the day for an adult IBS patient! “
“The effectiveness of human bone marrow mesenchymal stem cell (hBMSC) transplantation to treat acute and chronic liver injury has been demonstrated in animal models and in a few nonrandomized clinical trials. find more However, no studies have investigated hBMSC transplantation in the treatment of fulminant hepatic failure (FHF), especially in large animal (pig) models. The aim of this study was to demonstrate the safety, effectiveness, and underlying mechanism of hBMSC transplantation for treating FHF in pigs through the intraportal route. Human BMSCs (3 × 107) were transplanted into pigs with FHF via the intraportal route or peripheral vein immediately after D-galactosamine injection, and a sham group underwent intraportal transplantation MCE (IPT) without cells (IPT, peripheral vein transplantation [PVT], and control groups, respectively, n = 15 per group). All of the animals in the PVT

and control groups died of FHF within 96 hours. In contrast, 13 of 15 animals in the IPT group achieved long-term survival (>6 months). Immunohistochemistry demonstrated that transplanted hBMSC-derived hepatocytes in surviving animals were widely distributed in the hepatic lobules and the liver parenchyma from weeks 2 to 10. Thirty percent of the hepatocytes were hBMSC-derived. However, the number of transplanted cells decreased significantly at week 15. Only a few single cells were scattered in the regenerated liver lobules at week 20, and the liver tissues exhibited a nearly normal structure. Conclusion: Immediate IPT of hBMSCs is a safe and effective treatment for FHF. The transplanted hBMSCs may quickly participate in liver regeneration via proliferation and transdifferentiation into hepatocytes during the initial stage of FHF. This method can possibly be used in future clinical therapy.